Harvey AI Review (2026) — Is Enterprise Legal AI Worth the Price?
Harvey AI is the legal AI startup that raised $80 million from Sequoia Capital in 2023 — one of the largest AI funding rounds in legal tech. That kind of money buys a lot of hype. But does the product live up to it?
After talking to attorneys at firms that have access to Harvey, the picture is more nuanced than the press releases suggest. It’s targeting large law firms with an enterprise-grade AI assistant, and for that specific audience, it’s impressive. For everyone else, it’s currently out of reach.
But with a premium price tag and limited availability, is it worth pursuing? Here’s what we know.
What Harvey Does
Harvey positions itself as a general-purpose AI assistant for lawyers, with capabilities including:
- Legal research with citation verification
- Contract analysis and due diligence
- Document drafting with firm-specific templates
- Regulatory compliance analysis
- Litigation support including brief drafting and case analysis
The key selling point: Harvey is trained on legal data and fine-tuned for legal reasoning, not just a ChatGPT wrapper with legal prompts.
Pricing
Harvey doesn’t publish pricing. It’s enterprise-only, meaning:
- You need to contact sales for a quote
- Pricing is per-firm, likely based on number of users
- Expect $200-500+/user/month based on industry reports
- Multi-year contracts are common
This immediately puts it out of reach for solo practitioners and small firms.
The Pros
Legal-specific training
Harvey claims better legal reasoning than general AI tools because it’s been fine-tuned on legal documents, case law, and regulatory text. In practice, this means fewer hallucinations and more relevant output for legal tasks.
Firm customization
Harvey can be trained on your firm’s documents, templates, and style guides. Over time, it learns how your firm writes motions, structures contracts, and communicates with clients.
Enterprise security
SOC 2 compliant, data isolation per firm, no training on client data. This addresses the biggest concern law firms have about AI adoption.
Integration potential
Harvey is building integrations with document management systems, practice management tools, and legal research platforms. The goal is to embed AI into existing workflows rather than requiring lawyers to switch to a new tool.
The Cons
Availability
Harvey is still in limited rollout. Not every firm can get access, and the onboarding process takes weeks to months.
Cost
For the price of Harvey, a mid-size firm could buy CoCounsel subscriptions for every attorney and have budget left over. The ROI needs to be significant to justify the premium.
Unproven at scale
Harvey is relatively new. Long-term reliability, accuracy improvements, and support quality are still being established. Early adopters are essentially beta testers.
Vendor lock-in
Once your firm’s documents and workflows are integrated with Harvey, switching to a competitor becomes expensive and disruptive.
Harvey vs CoCounsel vs ChatGPT
| Feature | Harvey | CoCounsel | ChatGPT |
|---|---|---|---|
| Legal training | ✅ Deep | ✅ Westlaw-backed | ❌ General |
| Verified citations | ✅ Yes | ✅ Yes (Westlaw) | ❌ Fabricates |
| Firm customization | ✅ Yes | ⚠️ Limited | ❌ No |
| Price | $$$$$ | $$$ | $ |
| Availability | Limited | Wide | Universal |
| Best for | Am Law 200 | All firms | Individual lawyers |
Who Should Consider Harvey
- Large firms (50+ attorneys) with budget for enterprise AI
- Firms doing high-volume document review where AI customization pays off
- Firms that want a single AI platform rather than multiple point solutions
Who Should Skip It
- Solo and small firms — the cost doesn’t make sense
- Firms happy with CoCounsel — the incremental benefit may not justify the price difference
- Firms that need AI today — Harvey’s rollout timeline may not match your urgency
The Verdict
Harvey is building what could become the best AI platform for large law firms. The firm customization and legal-specific training are genuinely differentiated. But it’s expensive, limited in availability, and still early.
Rating: 3.5/5 — Promising but unproven at the price point. Check back in 12 months.